BeiGene, Ltd.

Informe acción SHSC:6160

Capitalización de mercado: HK$157.5b

BeiGene Propiedad

¿Quiénes son los principales accionistas, y ha habido compras o ventas con información privilegiada?


Operaciones recientes con información privilegiada

Transacciones recientes de empresas o particulares con información privilegiada de SHSC:6160
FechaValorNombreEntidadCargoAccionesPrecio máximo
22 Oct 24SellHK$89,577,727JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany687,359HK$130.32
25 Sep 24BuyHK$2,916,487JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany23,367HK$124.81
25 Sep 24BuyHK$482,427,235JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany3,865,225HK$124.81
25 Sep 24SellHK$13,629,492JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany109,200HK$124.81
25 Sep 24SellHK$7,230,870JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany57,934HK$124.81
24 Sep 24BuyHK$147,098JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany1,200HK$122.58
24 Sep 24SellHK$453,551JP Morgan Asset ManagementCompany3,700HK$122.58
24 Sep 24SellHK$9,267,032JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany75,599HK$122.58
24 Sep 24SellHK$1,952,942,894JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany15,931,804HK$122.58
23 Sep 24BuyHK$32,152,318JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany265,629HK$121.04
23 Sep 24BuyHK$1,249,803,161JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany10,325,351HK$121.04
23 Sep 24SellHK$689,941JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany5,700HK$121.04
20 Sep 24BuyHK$27,599JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany225HK$122.66
20 Sep 24BuyHK$303,678,733JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany2,475,730HK$122.66
20 Sep 24SellHK$5,034,183JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany41,041HK$122.66
13 Sep 24BuyHK$43,680,325JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany362,816HK$120.39
27 Aug 24SellHK$2,963,845John OylerIndividual24,479HK$121.08
14 Jun 24SellHK$179,217,653JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany1,814,866HK$98.75
19 Apr 24BuyHK$134,126JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany1,749HK$76.69
10 Apr 24SellHK$31,165,360John OylerIndividual347,308HK$89.73
09 Apr 24SellHK$13,500,329John OylerIndividual145,600HK$92.72
26 Mar 24SellHK$2,925,744John OylerIndividual31,681HK$92.35
12 Mar 24SellHK$48,338,194John OylerIndividual489,684HK$98.71

Volumen de trading con información privilegiada

Compra de información privilegiada: personas con información privilegiada de 6160 solo han vendido acciones en los últimos 3 meses.


Desglose de propiedad

¿Cuál es la estructura de propiedad de 6160?
Tipo de propietarioNúmero de accionesPorcentaje de participación
Plan de acciones para empleados138.2400,13 %
Empresas privadas379.5020,357 %
Personas con información privilegiada4.934.0164,64 %
Público general8.891.4998,37 %
Empresas públicas18.938.11917,8 %
Fondos de inversión libre20.850.30219,6 %
Instituciones52.114.51649,1 %

Dilución de acciones: Los accionistas se han diluido en el último año, con un crecimiento total de acciones en circulación de 2.1%.


Principales accionistas

Los 25 principales accionistas poseen un 79.81% de la empresa
PropiedadNombreAccionesValor actualVariación %% Cartera
17,8 %
Amgen Inc.
18.938.119HK$28.1b0 %Sin datos
9,95 %
Baker Bros. Advisors LP
10.576.080HK$15.7b0 %18,36 %
9,67 %
HHLR Advisors, Ltd.
10.274.222HK$15.2b0 %24,0 %
6,98 %
Capital Research and Management Company
7.412.076HK$11.0b-0,92 %0,07 %
4,87 %
Hillhouse Investment Management, Ltd.
5.176.906HK$7.7b400 %9,0 %
4,68 %
PRIMECAP Management Company
4.974.289HK$7.4b-0,24 %0,67 %
3,67 %
Baillie Gifford & Co.
3.895.891HK$5.8b0,66 %0,32 %
3,52 %
John Oyler
3.736.525HK$5.5b-10,2 %Sin datos
2,96 %
BlackRock, Inc.
3.140.055HK$4.7b11,5 %0,01 %
2,54 %
T. Rowe Price Group, Inc.
2.700.341HK$4.0b18,8 %0,04 %
2,28 %
The Vanguard Group, Inc.
2.421.941HK$3.6b23,8 %0,01 %
2,25 %
Temasek Holdings (Private) Limited
2.388.576HK$3.5b-20,8 %0,4 %
1,54 %
FMR LLC
1.640.542HK$2.4b0,9 %0,02 %
1,08 %
Bosera Asset Management Co., Ltd.
1.150.829HK$1.7b0 %1,01 %
1,03 %
Norges Bank Investment Management
1.090.871HK$1.6b0 %0,02 %
0,83 %
Xiaodong Wang
876.794HK$1.3b-3,01 %Sin datos
0,68 %
GF Fund Management Co., Ltd.
717.207HK$1.1b0 %0,31 %
0,64 %
Point72 Asset Management, L.P.
680.715HK$1.0b78,5 %0,32 %
0,53 %
Artal Group S.A.
563.314HK$835.0m85,7 %2,77 %
0,47 %
Tavistock Life Sciences
500.000HK$741.2m0 %6,03 %
0,42 %
China Asset Management Co. Ltd.
448.116HK$664.2m-3,51 %0,11 %
0,37 %
ICBC Credit Suisse Asset Management Co., Ltd.
398.099HK$590.1m0 %0,53 %
0,35 %
Guangzhou Development District Holding Group Limited
368.385HK$546.1m0 %Sin datos
0,35 %
SDIC Unity Capital Co., Ltd.
368.385HK$546.1m0 %7,17 %
0,33 %
Public Investment Fund
354.385HK$525.3m0 %0,03 %